Skip to main content
. Author manuscript; available in PMC: 2019 Jun 15.
Published in final edited form as: J Neuroimmunol. 2018 Mar 17;319:80–92. doi: 10.1016/j.jneuroim.2018.03.009

Fig. 5.

Fig. 5

GM-CSF modifies Aβ transporter levels in AD mice brain. (A) The expression of of LRP1 and RAGE in non-Tg and AD animal groups was determined by Western blot analysis. (B, C) Densitometric analysis of LRP1 (B) and RAGE (C) expression in GM-CSF-treated or untreated mice (n = 4 per group). Data are presented as mean intensity of expression ± SEM, and aap ≤ 0.01, bp≤0.05, bbp ≤ 0.01 and cp ≤ 0.05 compared to aanon-Tg/PBS, b,bbnon-Tg/GM-CSF, or cAD/PBS as determined by one-way ANOVA and Newman-Keuls post-hoc test.